首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of nanobiotechnology

缩写:J NANOBIOTECHNOL

ISSN:N/A

e-ISSN:1477-3155

IF/分区:12.6/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引4128
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Shixiong Wei,Rui-Juan Cheng,Sujia Li et al. Shixiong Wei et al.
Objective: As research into preclinical rheumatoid arthritis (pre-RA) has advanced, a growing body of evidence suggests that abnormalities in RA-affected joint cartilage precede the onset of arthritis. Thus, early prevent...
Yiqing Cao,Jianan Feng,Qiao Zhang et al. Yiqing Cao et al.
Bladder cancer (BCa) exhibits the escalating incidence and mortality due to the untimely and inaccurate early diagnosis. Urinary exosome metabolites, carrying critical tumor cell information and directly related to bladder, emerge as promis...
Yu Wang,Yilei Mo,Yingwei Sun et al. Yu Wang et al.
Orally administered nanocarriers play an important role in improving druggability, promoting intestinal absorption, and enhancing therapeutic applications for the treatment of local and systemic diseases. However, the delivering efficiency ...
Peng Yang,Shaojie Liu,Zhuang Chen et al. Peng Yang et al.
Background: Mn2+-mediated chemodynamic therapy (CDT) has been emerged as a promising cancer therapeutic modality that relies heavily on HCO3- level in the system. Although the physiological buffers (H2CO3/HCO3-) provide c...
Xuanxuan Ma,Na Yang,Ruoyu Mao et al. Xuanxuan Ma et al.
The wide-spreading of multidrug resistance poses a significant threat to human and animal health. Although antimicrobial peptides (AMPs) show great potential application, their instability has severely limited their clinical application. He...
Xiaodong Hou,Yuting Shen,Bin Huang et al. Xiaodong Hou et al.
Preclinical studies demonstrating high cure rates with PD1/PD-L1 combinations have led to numerous clinical trials, but emerging results are disappointing. These combined immunotherapies are commonly employed for patients with refractory tu...
Tianyu Wu,Wenwu Zhu,Rui Duan et al. Tianyu Wu et al.
Background: Contrast-induced acute kidney injury (CI-AKI) is manifested by a rapid decline in renal function occurring within 48-72 h in patients exposed to iodinated contrast media (CM). Although intravenous hydration is...
Wei-Jia Hu,Hong Wei,Li-Li Cai et al. Wei-Jia Hu et al.
Background: Treating mitochondrial dysfunction is a promising approach for the treatment of post-stroke cognitive impairment (PSCI). HuMSC-derived exosomes (H-Ex) have shown powerful therapeutic effects in improving mitoc...
Sijin Chen,Wenli Zhang,Chun Tang et al. Sijin Chen et al.
Atherosclerosis (AS) poses a significant threat to human life and health. However, conventional antiatherogenic medications exhibit insufficient targeting precision and restricted therapeutic effectiveness. Moreover, during the progression ...
Huiyang Liu,Yiming Lu,Jinbao Zong et al. Huiyang Liu et al.
Targeted immunotherapies make substantial strides in clinical cancer care due to their ability to counteract the tumor's capacity to suppress immune responses. Advances in biomimetic technology with minimally immunogenic and highly targeted...